Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 68: 1059-1068, 1990;
8750-7587/90 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, C. R.
Right arrow Articles by Chang, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, C. R.
Right arrow Articles by Chang, S. W.

Journal of Applied Physiology, Vol 68, Issue 3 1059-1068, Copyright © 1990 by American Physiological Society


ARTICLES

PAF potentiates protamine-induced lung edema: role of pulmonary venoconstriction

C. R. Chen, N. F. Voelkel and S. W. Chang
Cardiovascular Pulmonary Research Laboratory, University of Colorado Health Sciences Center, Denver 80262.

We studied the synergistic interaction between platelet-activating factor (PAF) and protamine sulfate, a cationic protein that causes pulmonary endothelial injury, in isolated rat lungs perfused with a physiological salt solution. A low dose of protamine (50 micrograms/ml) increased pulmonary artery perfusion pressure (Ppa) but did not increase wet lung-to-body weight ratio after 20 min. Pretreatment of the lungs with a noninjurious dose of PAF (1.6 nM) 10 min before protamine markedly potentiated protamine-induced pulmonary vasoconstriction and resulted in severe lung edema and increased lung tissue content of 6-keto-prostaglandin F1 alpha, thromboxane B2, and leukotriene C4. Pulmonary microvascular pressure (Pmv), measured by double occlusion, was markedly increased in lungs given PAF and protamine. These potentiating effects of PAF were blocked by WEB 2086 (10(-5) M), a specific PAF receptor antagonist. Pretreatment of the lungs with a high dose of histamine (10(-4) M) failed to enhance the effect of protamine on Ppa, Pmv, or wet lung-to-body weight ratio. Furthermore, PAF pretreatment enhanced elastase-, but not H2O2-, induced lung edema. To assess the role of hydrostatic pressure in edema formation, we compared lung permeability-surface area products (PS) in papaverine-treated lungs given either protamine alone or PAF + protamine and tested the effect of mechanical elevation of Pmv on protamine-induced lung edema. In the absence of vasoconstriction, PAF did not potentiate protamine-induced increase in lung PS. On the other hand, mechanically raising Pmv in protamine-treated lungs to a level similar to that measured in lungs given PAF + protamine did not result in a comparable degree of lung edema. We conclude that PAF potentiates protamine-induced lung edema predominantly by enhanced pulmonary venoconstriction. However, a pressure-independent effect of PAF on lung vasculature cannot be entirely excluded.


This article has been cited by other articles:


Home page
ScienceHome page
M. Berthe, R. Stiufiuc, B. Grandidier, D. Deresmes, C. Delerue, and D. Stievenard
Probing the Carrier Capture Rate of a Single Quantum Level
Science, January 25, 2008; 319(5862): 436 - 438.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Gao, S. Dhanakoti, E. M. Trevino, F. C. Sander, A. M. Portugal, and J. U. Raj
Effect of oxygen on cyclic GMP-dependent protein kinase-mediated relaxation in ovine fetal pulmonary arteries and veins
Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L611 - L618.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
O. DAZ, J. A. BARBER, R. MARRADES, K. CHUNG, J. ROCA, and R. RODRIGUEZ-ROISIN
Inhibition of PAF-induced Gas Exchange Defects by Beta-adrenergic Agonists in Mild Asthma Is Not Due to Bronchodilation
Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 17 - 22.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
Y. Gao, H. Zhou, and J. U. Raj
Endothelium-Derived Nitric Oxide Plays a Larger Role in Pulmonary Veins Than in Arteries of Newborn Lambs
Circ. Res., April 1, 1995; 76(4): 559 - 565.
[Abstract] [Full Text]


Home page
VASC ENDOVASCULAR SURGHome page
D. S. Kucukaksu, S. F. Katircioglu, G. Saydam, M. Bozdayi, B. Mavitas, O. Tasdemir, and K. Bayazit
Beneficial Effects of Prostacyclin on Pulmonary Function During Heparin Reversal with Protamine
Vascular and Endovascular Surgery, May 1, 1993; 27(4): 264 - 267.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online